Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerstin Jr., E. H.
Right arrow Articles by Messing, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerstin Jr., E. H.
Right arrow Articles by Messing, R. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 26, 16409-16414, June 26, 1998


Protein Kinase Cdelta Mediates Ethanol-induced Up-regulation of L-type Calcium Channels*

Edward H. Gerstin Jr.Dagger §, Thomas McMahonDagger §, Jahan DadgarDagger , and Robert O. MessingDagger parallel

From the Dagger  Department of Neurology, Ernest Gallo Clinic and Research Center and the  Graduate Programs in Neuroscience and Biomedical Sciences, University of California, San Francisco, California 94110

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Brief ethanol exposure inhibits L-type, voltage-gated calcium channels in neural cells, whereas chronic exposure increases the number of functional channels. In PC12 cells, this adaptive response is mediated by protein kinase C (PKC), but the PKC isozyme responsible is unknown. Since chronic ethanol exposure increases expression of PKCdelta and PKCepsilon , we investigated the role these isozymes play in up-regulation of L-type channels by ethanol. Incubation with the PKC inhibitor GF 109203X or expression of a PKCdelta fragment that inhibits phorbol ester-induced PKCdelta translocation largely prevented ethanol-induced increases in dihydropyridine binding and K+-stimulated 45Ca2+ uptake. A corresponding PKCepsilon fragment had no effect on this response. These findings indicate that PKCdelta mediates up-regulation of L-type channels by ethanol. Remaining responses to ethanol in cells expressing the PKCdelta fragment were not inhibited by GF 109203X, indicating that PKCdelta -independent mechanisms also contribute. PKCdelta overexpression increased binding sites for dihydropyridine and L-channel antagonists, but did not increase K+-stimulated 45Ca2+ uptake, possibly because of homeostatic responses that maintain base-line levels of channel function. Since L-type channels modulate drinking behavior and contribute to neuronal hyperexcitability during alcohol withdrawal, these findings suggest an important role for PKCdelta in alcohol consumption and dependence.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Understanding biochemical mechanisms that underlie alcohol tolerance and dependence may lead to new treatments for alcoholism. In nonalcoholic persons, intoxication develops at blood alcohol levels of 10-35 mM, and acute tolerance develops rapidly, so that after a few hours, an individual can appear sober at alcohol levels that previously caused intoxication (1). The mechanism for acute tolerance may involve activation of Fyn kinase and reduced sensitivity of tyrosine-phosphorylated N-methyl-D-aspartate receptors to inhibition by alcohol (2). Chronic tolerance is characteristic of alcoholism, and its magnitude in alcoholics can be quite striking. For example, blood alcohol concentrations above 100 mM produce coma in a nonalcoholic person, whereas human alcoholics may appear sober or only mildly intoxicated with blood levels of 100-150 mM (3, 4).

The ability of ethanol to alter the function of neuronal voltage-dependent calcium channels appears to contribute to chronic tolerance. In several neural preparations, ethanol inhibits voltage-dependent calcium influx and calcium currents (5-13). Chronic exposure results in the development of tolerance to the inhibitory actions of ethanol on calcium channels (6, 7). The mechanisms underlying this adaptive response have been studied most in the neural cell line PC12. In PC12 cells, prolonged exposure to 25-200 mM ethanol for 2-6 days produces a reversible concentration- and time-dependent increase in K+-evoked 45Ca2+ uptake (8, 9, 14) and L-type calcium currents (14) measured in the absence of ethanol. This is associated with a corresponding increase in the number of binding sites for dihydropyridine Ca2+ channel antagonists (8, 9), suggesting that cells adapt to chronic ethanol exposure by increasing expression of functional L-type calcium channels. Similar increases in dihydropyridine binding have been detected in ethanol-treated NG108-15 neuroblastoma × glioma cells (15) and in brain membranes from ethanol-treated rats (16).

Up-regulation of L-type channels could promote alcohol consumption since L-channel antagonists reduce consumption in animals (17-20). Increases in L-type calcium channels may also contribute to the intense neuronal hyperexcitability observed during alcohol withdrawal (21). A role for L-type channels in alcohol withdrawal syndromes is supported by evidence that L-channel antagonists reduce tremors, seizures, and mortality in alcohol-dependent rodents deprived of ethanol (22-24). Moreover, ethanol-induced increases in binding sites for L-channel antagonists are greater in mice bred for severe alcohol withdrawal seizures than in mice bred for minor signs of alcohol withdrawal (25). These findings suggest that L-channel up-regulation plays an important role in alcohol dependence.

Protein kinase C (PKC)1 is a family of phospholipid-dependent serine/threonine kinases involved in cell growth and differentiation, neurotransmitter release and receptor regulation, ion channel modulation, and gene expression (26). Eleven PKC isozymes have been identified (alpha , beta I, beta II, gamma , delta , epsilon , zeta , eta , theta , lambda , and µ), and they differ in structure and requirements for activation by diacylglycerol and calcium (26-28). In PC12 cells, we found that up-regulation of L-type channels by ethanol is inhibited by the kinase inhibitors sphingosine and polymyxin B (29). The effect of sphingosine is reversed by phorbol esters that activate all PKC isozymes except PKCzeta and PKClambda (26), suggesting that ethanol-induced up-regulation of L-type channels requires activation of a phorbol ester-sensitive PKC. We also found that chronic ethanol exposure increases total PKC activity, high affinity phorbol ester binding, and PKC-mediated phosphorylation in PC12 cells (30). This is associated with a selective increase in immunoreactivity (30) and mRNA (31) for two PKC isozymes, PKCdelta and PKCepsilon . Taken together, these findings suggest that chronic exposure to ethanol up-regulates functional L-type channels through a mechanism that involves ethanol-induced increases in expression of PKCdelta or PKCepsilon .

In this paper, we examined whether PKCdelta or PKCepsilon mediates ethanol-induced increases in L-type channels by using stably transfected PC12 cell lines that express the delta V1 or epsilon V1 fragment, which are derived from the first variable domains of PKCdelta and PKCepsilon , respectively. These fragments selectively inhibit phorbol ester-induced translocation of the corresponding isozyme, and the epsilon V1 fragment specifically prevents phorbol ester-mediated inhibition of contraction in cultured cardiac myocytes (32) and enhancement of nerve growth factor-induced neurite outgrowth and mitogen-activated protein kinase activation by ethanol or phorbol esters in PC12 cells (33). We found that chronic exposure to ethanol increased K+-stimulated 45Ca2+ uptake and dihydropyridine binding in PC12 cells, vector-transfected cells, and cells expressing epsilon V1, but not in cells expressing delta V1. We also found that overexpression of PKCdelta increased dihydropyridine binding, but did not enhance K+-stimulated 45Ca2+ uptake. These results demonstrate that PKCdelta mediates increases in L-type calcium channels induced by chronic exposure to ethanol. These results are the first to demonstrate a functional role for PKCdelta in neural cells.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cell Culture-- In these experiments, we used PC12 cells obtained from Dr. John A. Wagner (Cornell University, New York). Cells were grown at 37 °C in plastic tissue culture flasks in Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum, 10% horse serum, 50 units/ml penicillin, 50 µg/ml streptomycin, and 2 mM glutamine in a humidified atmosphere of 90% air and 10% CO2. Cells were cultured with ethanol in tightly capped tissue culture flasks or in six-well plates wrapped in Parafilm, and the medium was changed daily as described previously (8, 29). Parallel control samples were cultured in a similar manner without ethanol. Stably transfected cell lines that overexpress PKCdelta or PKCepsilon have been described previously (34). Cell lines that express Flag epitope-tagged delta V1 or epsilon V1 were created and analyzed by reverse transcriptase-polymerase chain reaction and Western analysis for the Flag epitope tag as described (33).

Phorbol Ester-stimulated Translocation of PKCdelta -- Cells (4 × 106) were plated on 100-mm2 plastic tissue culture plates. After 2 days, the plates were rinsed with 10 ml of Dulbecco's modified Eagle's medium and incubated with or without 30 nM phorbol 12-myristate 13-acetate (PMA) for 2 min at 37 °C. Cells were rinsed twice with Ca2+- and Mg2+-free phosphate-buffered saline and scraped into ice-cold buffer containing 20 mM Tris-HCl, pH 7.5, 2 mM EDTA, 10 mM EGTA, 40 µg/ml leupeptin, 40 µg/ml aprotinin, 20 µg/ml soybean trypsin inhibitor, and 1 mM phenylmethylsulfonyl fluoride. Cells were homogenized in a Teflon-glass homogenizer, and sucrose was added to a final concentration of 250 mM. Samples were then centrifuged at 150,000 × g for 1 h, and the supernatant was saved as the cytosolic fraction. The pellet was dispersed by sonication, and samples of supernatant and pellet derived from 100 µg of crude homogenate were analyzed by Western analysis as described (33).

K+-stimulated 45Ca2+ Uptake-- PC12 cells were plated onto poly-D-lysine-coated six-well tissue culture plates at a density of 0.8-1.6 × 106 cells/well. After 24 h, cells were cultured for another 1-6 days in the presence or absence of ethanol. On the day of assay, cells were rinsed twice with 1 ml of 5 mM KCl buffer (85 mM NaCl, 5 mM KCl, 45 mM choline chloride, 2 mM CaCl2, 5 mM glucose, and 25 mM HEPES, pH 7.4) at room temperature, and incubated in the same buffer for 25 min. Cells were then incubated at 25 °C in 5 or 50 mM KCl buffer containing 0.75 µCi of 45Ca2+. The composition of the 50 mM KCl buffer was identical to that of the 5 mM KCl buffer except that choline chloride was replaced by KCl. After incubation for 2.5 min, cells were washed four times with 2.5 ml of ice-cold 5 mM KCl buffer and incubated overnight with 1 ml of 1 M NaOH. Radioactivity in neutralized samples was measured by liquid scintillation counting, and protein levels were determined by the method of Lowry et al. (35). K+-stimulated uptake is defined as the difference between uptake in 50 and 5 mM KCl buffers and represents 85 ± 1% (n = 10) of total uptake in 50 mM KCl buffer.

(+)-[3H]PN200-110 Binding-- Binding of (+)-[3H]PN200-110 to whole cells was measured as described previously (36). Specific binding was determined by subtracting binding in the presence of 1 µM nimodipine from binding in its absence and represents 51 ± 2% (n = 10) of total binding at 50 pM radioligand.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

GF 109203X Prevents Ethanol-induced Increases in K+-stimulated 45Ca2+ Uptake-- Previous work suggested that up-regulation of L-type channels by ethanol requires activation of PKC since it is prevented by the nonselective PKC inhibitors sphingosine and polymyxin B (29). Since we had used a different clone of PC12 cells for these earlier studies, we needed to determine whether our current PC12 cell line responds similarly to ethanol. In control cells, 45Ca2+ uptake was 3.6 ± 0.21 nmol of Ca2+/mg of protein/2.5 min (n = 103) and was inhibited 92 ± 2% by the L-type channel antagonist nimodipine (1 µM). Exposure to 25-150 mM ethanol for 1-6 days increased K+-stimulated 45Ca2+ uptake assayed in the absence of ethanol (Fig. 1 A and B). This is similar to the increase we observed previously with another PC12 cell line (8), except that a maximal response was achieved at 6 days in those cells instead of at 5 days as observed in the current cell line. To examine whether the increase in K+-stimulated 45Ca2+ uptake was PKC-dependent, we cultured cells in the presence of 1 µM GF 109203X, which is a relatively selective PKC inhibitor that inhibits all phorbol ester-sensitive PKC isozymes except PKCµ (37, 38). As shown in Fig. 1A, GF 109203X prevented increases in K+-stimulated 45Ca2+ uptake induced by treatment with 150 mM ethanol for 6 days. Thus, ethanol appears to increase K+-stimulated 45Ca2+ uptake in these cells by a PKC-dependent mechanism.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Time course and concentration dependence of increases in K+-stimulated 45Ca2+ uptake following exposure to ethanol. A, 45Ca2+ uptake was measured in PC12 cells cultured with 150 mM ethanol (bullet ). Some cultures were treated with 1 µM GF 109203X with (black-triangle) or without (triangle ) ethanol. B, 45Ca2+ uptake was measured in PC12 cells cultured for 6 days in the indicated concentrations of ethanol. The data shown are the means ± S.E. (n = 3-16) and are expressed as the percent above 45Ca2+ uptake measured in parallel control cells cultured without ethanol.

Characterization of V1-expressing Cell Lines-- To investigate whether PKCdelta or PKCepsilon is required for up-regulation of L-type calcium channels by ethanol, we created PC12 cell lines that stably express V1 fragments derived from the first variable domains of PKCdelta (delta V1) and PKCepsilon (epsilon V1). These fragments inhibit phorbol ester-induced translocation and activation of their corresponding PKC isozyme (32, 33). Characterization of epsilon V1-expressing PC12 cell lines (V1epsilon 1 and V1epsilon 2) was described recently (33). Expression of the delta V1 fragment in V1delta 2, V1delta 3, and V1delta 4 cells was confirmed by reverse transcriptase-polymerase chain reaction (Fig. 2A) and Western analysis (Fig. 2B). Treatment with 30 nM PMA stimulated translocation of both PKCdelta and PKCepsilon to the particulate fraction in the parent PC12 cell line and in C cells transfected with vector alone (Fig. 2, C and D). However, in cell lines expressing the delta V1 fragment, translocation of PKCdelta was inhibited, whereas translocation of PKCepsilon was not (Fig. 2, C and D). In contrast, PMA-induced translocation of PKCepsilon is selectively inhibited in epsilon V1-expressing lines (33). Thus, expression of delta V1 or epsilon V1 fragments selectively inhibits phorbol ester-stimulated translocation of the corresponding PKC isozyme in these cells.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   Characterization of stably transfected PC12 cells expressing Flag epitope-tagged delta V1. A, reverse transcriptase-polymerase chain reaction products were analyzed on 1.2% agarose gels to demonstrate expression of delta V1-Flag mRNA in clones V1delta 2, V1delta 3, and V1delta 4. No product was found in PC12 cells or C cells transfected with vector alone. kb, kilobase; Std, DNA size markers. B, lysates of V1delta 2, V1delta 3, and V1delta 4 cells were analyzed on Western blots to detect the presence of 17-kDa Flag immunoreactivity that comigrates with purified Flag-tagged delta V1 expressed in bacteria (delta -Flag). C, cells were treated with 30 nM PMA for 2 min to induce PKC translocation and then fractionated into cytosolic (Cy) and particulate (P) cell fractions. PKCdelta and PKCepsilon immunoreactivity in cell fractions was detected by Western analysis. The data shown are from a representative experiment. D, PKC isozyme-specific immunoreactivity on Western blots of cytosolic and particulate fractions was quantified by scanning densitometry and is expressed as a percentage of total immunoreactivity. PKC isozyme translocation was then calculated as the increase in isozyme-specific immunoreactivity found in the particulate fraction following treatment with PMA. The data shown are the means ± S.E. from four to seven experiments. *, p < 0.01 compared with PC12 or C cells (ANOVA and Newman-Keuls test).

The delta V1 Fragment Prevents Ethanol-induced Increases in K+-stimulated 45Ca2+ Uptake-- To determine whether PKCdelta or PKCepsilon mediates ethanol-induced increases in L-type channel function, we measured K+-stimulated 45Ca2+ uptake in cells expressing delta V1 or epsilon V1. Expressed as a percentage of K+-stimulated 45Ca2+ uptake measured in PC12 cells, uptake was similar (p = 0.11; ANOVA) in C (88 ± 6%, n = 23), V1delta 2 (107 ± 10%, n = 15), V1delta 3 (118 ± 7%, n = 6), V1delta 4 (85 ± 6%, n = 8), V1epsilon 1 (101 ± 7%, n = 6), and V1epsilon 2 (98 ± 5%, n = 6) cells. Treatment with 150 mM ethanol for 6 days increased 45Ca2+ uptake in PC12, C, and epsilon V1-expressing cells to a similar extent (Fig. 3A). In contrast, ethanol was much less effective in increasing 45Ca2+ uptake in cells expressing the delta V1 fragment (Fig. 3A).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Ethanol-induced increases in 45Ca2+ uptake and dihydropyridine binding are inhibited in cells expressing delta V1. Cells were treated with 150 mM ethanol for 6 days. A, depolarization-induced 45Ca2+ uptake was measured in PC12 cells, vector-transfected cells (C), and cells expressing the delta V1 fragment (V1delta 2, V1delta 3, or V1delta 4) or the epsilon V1 fragment (V1epsilon 1 or V1epsilon 2). The data shown are the means ± S.E. (n = 5-24) and are expressed as the percent above 45Ca2+ uptake measured in parallel control cells cultured without ethanol. *, p < 0.05 compared with PC12 or C cells (ANOVA and Newman-Keuls test). B, binding of (+)-[3H]PN200-110 was measured in depolarized cells, and the results are expressed as the percent above or below specific binding measured in parallel control cells cultured without ethanol. The data shown are the means ± S.E. (n = 6-9). *, p < 0.05 compared with PC12 or C cells (ANOVA and Newman-Keuls test).

The delta V1 Fragment Prevents Ethanol-induced Increases in Dihydropyridine Binding-- To determine if expression of the delta V1 fragment also prevents ethanol-induced increases in dihydropyridine binding, we measured binding of the L-type calcium channel antagonist (+)-[3H]PN200-110 to ethanol-treated cells (36). For these studies, we selected the two delta V1-expressing clones in which the response to ethanol was most inhibited in the 45Ca2+ uptake assay. Basal (+)-[3H]PN200-110 binding to PC12 cells was 3.52 ± 0.43 fmol/mg (n = 15) and was similar (p = 0.14; ANOVA) to binding measured in C (4.43 ± 0.42 fmol/mg, n = 7), V1delta 2 (3.78 ± 0.64 fmol/mg, n = 8), V1delta 3 (4.85 ± 0.49 fmol/mg, n = 7), V1epsilon 1 (3.17 ± 0.32 fmol/mg, n = 8), and V1epsilon 2 (3.17 ± 0.37 fmol/mg, n = 6) cells. Treatment with 150 mM ethanol for 6 days increased binding to a similar extent in PC12, C, V1epsilon 1, and V1epsilon 2 cells (Fig. 3B). In contrast, ethanol failed to increase binding in V1delta 2 and V1delta 3 cells. These results suggest that PKCdelta is required for up-regulation of L-type channels by ethanol.

Overexpression of PKCdelta -- To examine whether increases in PKCdelta are sufficient to increase L-channel density, we examined (+)-[3H]PN200-110 binding in PC12 cell lines delta 1 and delta 2, which overexpress PKCdelta (34). Compared with nontransfected PC12 cells, binding of 50 pM (+)-[3H]PN200-110 was increased in delta 1 and delta 2 cells, but not in C cells transfected with vector alone (Fig. 4). To determine whether the increase in binding in PKCdelta -overexpressing cells was due to a change in binding affinity or binding site number, binding was measured in delta 2 cells at increasing concentrations of (+)-[3H]PN200-110 (from 10 to 280 pM). Fig. 5 shows a representative experiment. Scatchard analysis yielded similar values for the equilibrium dissociation constant (KD) in PC12 (84 ± 4 pM) and delta 2 (102 ± 14 pM) cells (p = 0.27; n = 3). In contrast, the maximal number of binding sites (Bmax) in delta 2 cells (16.8 ± 1.9 fmol/mg) was greater (p < 0.028; n = 3) than the Bmax in PC12 cells (10.0 ± 0.7 fmol/mg). These findings are consistent with an increase in L-channel density rather than an increase in binding affinity in cells that overexpress PKCdelta . However, despite the increase in dihydropyridine binding, K+-stimulated 45Ca2+ uptake was not increased in delta 1 or delta 2 cells (Fig. 4).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   K+-stimulated 45Ca2+ uptake and dihydropyridine binding in cells that overexpress PKCdelta . K+-stimulated 45Ca2+ uptake (gray bars) and binding of 50 pM (+)-[3H]PN200-110 (black bars) were measured in delta 1 and delta 2 cells that overexpress rat PKCdelta and in C cells transfected with vector alone. The data shown are the means ± S.E. from 3 to 19 experiments and are expressed as the percent of uptake and binding above or below that measured in parallel cultures of PC12 cells. *, p < 0.016 by one-sample t test.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Saturation analysis of (+)-[3H]PN200-110 specific binding in PC12 and delta 2 cells. Data from saturation isotherms (A) were converted to Scatchard plots (B), and values for KD (-1/slope) and Bmax (x intercept) were determined by linear regression analysis. The data shown are from a representative experiment performed in triplicate. Mean KD and Bmax ± S.E. from three experiments are given under "Results."

PKCdelta -independent Regulation of L-type Channels by Ethanol-- Since overexpression of PKCdelta increased dihydropyridine binding but not K+-stimulated 45Ca2+ uptake, we considered whether enhancement of L-channel function by ethanol requires additional, PKCdelta -independent mechanisms. Initial evidence for a PKCdelta -independent mechanism was obtained by examining delta V1-expressing cells treated with ethanol and PKC inhibitors. Although treatment with GF 109203X substantially inhibited ethanol-induced increases in K+-stimulated 45Ca2+ uptake in PC12 cells (Fig. 1A), in V1delta 4 cells, it did not prevent increases due to ethanol, which were 26 ± 3% of control in the absence and 25 ± 5% of control in the presence of GF 109203X (p = 0.9; n = 6). This result indicates that a PKCdelta -independent mechanism activated by ethanol contributes to L-channel up-regulation. To examine if such a PKCdelta -independent mechanism is required to increase L-channel function in PKCdelta -overexpressing cells, we treated delta 1 and delta 2 cells with 150 mM ethanol for 5 days. We predicted that this treatment would markedly increase 45Ca2+ uptake with little or no effect on dihydropyridine binding. Ethanol enhanced K+-stimulated 45Ca2+ uptake in these cells (Fig. 6A) without increasing PKCdelta immunoreactivity (Fig. 6B), consistent with activation of a PKCdelta -independent mechanism. However, the increase in 45Ca2+ uptake was modest and associated with a similar increase in dihydropyridine binding (Fig. 6A).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Ethanol treatment of PKCdelta -overexpressing cells. Cells were treated with 150 mM ethanol for 5 days. A, K+-stimulated 45Ca2+ uptake (stippled bars) and binding of 50 pM (+)-[3H]PN200-110 (black bars) were measured in PC12 cells and in delta 1 and delta 2 cells that overexpress PKCdelta . The data shown are the means ± S.E. from three to eight uptake experiments and four binding experiments and are expressed as the percent of uptake or binding above that measured in parallel control cultures of each cell line treated without drugs. Ethanol-induced increases in 45Ca2+ uptake and dihydropyridine binding in delta 1 and delta 2 cells were significantly less than in PC12 cells (p < 0.05; ANOVA and Newman-Keuls test). B, shown is the PKCdelta immunoreactivity on Western blots of total cell lysates (mean ± S.E., n = 2). Inset, Western blot of control (C) and ethanol-treated (E) cells from a representative experiment. The data shown are expressed as the percent of PKCdelta immunoreactivity above or below that measured in parallel control cultures of each cell line treated without ethanol.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In this paper, we found that ethanol-induced increases in L-channel density and function were largely prevented by expression of delta V1, a selective inhibitor of PKCdelta translocation. In contrast, expression of epsilon V1, which inhibits PKCepsilon translocation, did not prevent L-channel up-regulation. Expression of delta V1 did not alter L-channel density or function in the absence of ethanol. These results indicate that PKCdelta , but not PKCepsilon , is important for ethanol-induced increases in functional L-type calcium channels in PC12 cells, but not for the basal activity of these channels.

Since ethanol increases the abundance of PKCdelta (30), we examined whether overexpression of PKCdelta would mimic the effect of ethanol on L-channel density and function. Although PKCdelta overexpression increased the number of dihydropyridine-binding sites in PC12 cells, it did not increase K+-stimulated 45Ca2+ uptake. This could have occurred because PKCdelta -independent mechanisms are also required to increase channel function. Two results provided evidence for PKCdelta -independent mechanisms that are activated by ethanol. In V1delta 4 cells, PKCdelta translocation was completely blocked with only partial suppression of the response to ethanol, and the remaining ethanol-induced response was resistant to the PKC inhibitor GF 109203X. Moreover, in PKCdelta -overexpressing cells, ethanol increased K+-stimulated 45Ca2+ uptake and dihydropyridine binding without a further increase in PKCdelta immunoreactivity. These findings indicate that PKCdelta -independent mechanisms contribute to up-regulation of L-type channels by ethanol.

If PKCdelta -independent mechanisms activated by ethanol are required for increases in L-channel function, treatment of PKCdelta -overexpressing cells with ethanol should have markedly increased 45Ca2+ uptake to levels commensurate with levels of dihydropyridine binding in these cells. However, this did not occur. PKCdelta overexpression alone increased dihydropyridine binding by ~1.6-fold (Fig. 4), and ethanol treatment by another 1.4-fold (Fig. 6), for a combined increase of 2.2-fold over binding in untreated PC12 cells. In contrast, PKCdelta overexpression and ethanol treatment together only increased 45Ca2+ uptake by 1.4-fold over uptake in untreated PC12 cells (Figs. 4 and 6). It appears that inactivity of PKCdelta -independent mechanisms cannot explain why PKCdelta overexpression alone increased L-channel density, but not L-channel function.

It is possible that increases in channel density evoked by stable overexpression of PKCdelta activate homeostatic mechanisms that reduce channel function to maintain a set level of calcium signaling. These mechanisms could act by decreasing L-channel function through altered subunit composition or phosphorylation or by increasing calcium efflux through increased Na+-Ca2+ exchange and the action of membrane ATPases (39). Homeostatic mechanisms that regulate channel density are activated by treatments that alter L-channel activity. For example, prolonged treatment with drugs such as ethanol (8, 9, 14-16), morphine (40), or nifedipine (41), which inhibit L-channel activity, increases L-channel density. In contrast, prolonged activation by exposure to depolarizing concentrations of KCl (42) or the L-channel agonist Bay K8644 (43) decreases L-channel density. It appears that L-channel function is highly regulated, and any alteration in channel activity or density leads to compensatory responses that serve to normalize function in the continued presence of the perturbing stimulus. Further studies will be needed to identify these compensatory mechanisms and to determine if they are activated in PKCdelta -overexpressing cells.

One mechanism by which ethanol, acting via PKCdelta , could increase L-channel density is by increasing expression of channel subunits. Neuronal high voltage-activated calcium channels are multimeric complexes of at least three types of subunits: alpha 1, alpha 2delta , and beta (44). The major pharmacological and physiological features that distinguish different classes of voltage-gated channels are mainly due to alpha 1 subunits, which contain the calcium pore and binding sites for selective calcium channel antagonists. There are five genes known to encode alpha 1 subunits in brain (alpha 1A, alpha 1B, alpha 1C, alpha 1D, and alpha 1E), and alpha 1C and alpha 1D are subunits of L-type channels (45-48). PC12 cells express alpha 1C (49). Transfected alpha 1C can form functional L-type channels, and coexpression with alpha 2delta or beta  subunits results in increased channel function and a corresponding increase in dihydropyridine binding (47, 50-54). Thus, ethanol-induced increases in abundance of alpha 1C, alpha 2delta , or beta  subunits could increase the number of functional L-type channels. This might occur at a transcriptional level since PKCdelta activates AP-1/Jun-regulated gene expression (55, 56). Studies are currently underway to determine if chronic exposure to ethanol regulates expression of specific calcium channel subunits by a PKCdelta -dependent mechanism.

PKCdelta is ubiquitously expressed and has been implicated in control of cell growth (56-58), apoptosis (59), and exocytosis (60) in non-neuronal cells. Little is known about its role in neuronal cells. It is induced in rat brain through an N-methyl-D-aspartate receptor-dependent mechanism after transient focal ischemia (61), but its role in brain injury or repair is not known. PKCdelta binds to the growth-associated protein GAP-43 and appears to act as a GAP-43 kinase (62). However, it is not yet clear if PKCdelta specifically regulates functions such as neurite growth or neurotransmitter release, which appear to be modulated by GAP-43 (63, 64). Our results provide the first evidence of a functional role for PKCdelta in neural cells. Our findings identify PKCdelta as a regulator of L-channel density and a mediator of cellular adaptation to ethanol. Since L-type channels modulate drinking behavior (17-20) and contribute to manifestations of alcohol withdrawal (22-24), PKCdelta may play a key role in alcohol consumption and dependence. Ongoing studies will determine if inhibition of PKCdelta reduces ethanol consumption and the development of alcohol dependence in animals.

    FOOTNOTES

* This work was supported by grants from the National Institute on Alcohol Abuse and Alcoholism and from the Alcoholic Beverage Medical Research Foundation (to R. O. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

parallel To whom correspondence and reprint requests should be addressed: Bldg. 1, Rm. 101, 1001 Potrero Ave., San Francisco, CA 94110. Tel.: 415-648-7111; Fax: 415-648-7116; E-mail: romes{at}itsa.ucsf.edu.

1 The abbreviations used are: PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; ANOVA, analysis of variance.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Goldstein, D. B. (1983) Pharmacology of Alcohol, Oxford University Press, New York
  2. Miyakawa, T., Yagi, T., Kitazawa, H., Yasuda, M., Kawai, N., Tsuboi, K., and Niki, H. (1997) Science 278, 698-701[Abstract/Free Full Text]
  3. Urso, T., Gavaler, J. S., and Van Thiel, D. H. (1981) Life Sci. 28, 1053-1056[CrossRef][Medline] [Order article via Infotrieve]
  4. Lindblad, B., and Olsson, R. (1976) J. Am. Med. Assoc. 236, 1600-1602[Abstract/Free Full Text]
  5. Oakes, S. G., and Pozos, R. S. (1982) Dev. Brain Res. 5, 251-255
  6. Harris, R. A., and Hood, W. F. (1980) J. Pharmacol. Exp. Ther. 213, 562-568[Abstract/Free Full Text]
  7. Leslie, S. W., Barr, E., Chandler, J., and Farrar, R. P. (1983) J. Pharmacol. Exp. Ther. 225, 571-575[Abstract/Free Full Text]
  8. Messing, R. O., Carpenter, C. L., and Greenberg, D. A. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 6213-6215[Abstract/Free Full Text]
  9. Skattebol, A., and Rabin, R. (1987) Biochem. Pharmacol. 36, 2227-2229[CrossRef][Medline] [Order article via Infotrieve]
  10. Twombly, D. A., Herman, M. D., Kye, C. H., and Narahashi, T. (1990) J. Pharmacol. Exp. Ther. 254, 1029-1037[Abstract/Free Full Text]
  11. Mullikin-Kilpatrick, D., and Treistman, S. N. (1995) J. Pharmacol. Exp. Ther. 272, 489-497[Abstract/Free Full Text]
  12. Mullikin-Kilpatrick, D., Mehta, N. D., Hildebrandt, J. D., and Treistman, S. N. (1995) Mol. Pharmacol. 47, 997-1005[Abstract]
  13. Wang, X., Wang, G., Lemos, J. R., and Treistman, S. N. (1994) J. Neurosci. 14, 5453-5460[Abstract]
  14. Grant, A. J., Koski, G., and Treistman, S. N. (1993) Brain Res. 600, 280-284[CrossRef][Medline] [Order article via Infotrieve]
  15. Bergamaschi, S., Battaini, F., Trabucchi, M., Parenti, M., Lopez, C. M., and Govoni, S. (1995) Alcohol 12, 497-503[CrossRef][Medline] [Order article via Infotrieve]
  16. Dolin, S., Little, H., Hudspith, M., Pagonis, C., and Littleton, J. (1987) Neuropharmacology 26, 275-279[CrossRef][Medline] [Order article via Infotrieve]
  17. Fadda, F., Garau, B., Colombo, G., and Gessa, G. L. (1992) Alcohol Clin. Exp. Res. 16, 449-452[CrossRef][Medline] [Order article via Infotrieve]
  18. Colombo, G., Agabio, R., Lobina, C., Reali, R., Fadda, F., and Gessa, G. L. (1994) Eur. J. Pharmacol. 265, 167-170[CrossRef][Medline] [Order article via Infotrieve]
  19. Rezvani, A. H., and Janowsky, D. S. (1990) Prog. Neuro-Psychopharmacol. Biol. Psychiatry 14, 623-631[CrossRef][Medline] [Order article via Infotrieve]
  20. Rezvani, A. H., Grady, D. R., and Janowsky, D. S. (1991) Alcohol Alcohol. 26, 161-167[Abstract/Free Full Text]
  21. Victor, M., and Adams, R. D. (1953) Res. Publ. Assoc. Res. Nerv. Ment. Dis. 32, 526-573[Medline] [Order article via Infotrieve]
  22. Bone, G. H., Majchrowicz, E., Martin, P. R., Linnoila, M., and Nutt, D. J. (1989) Psychopharmacology 99, 386-388[CrossRef][Medline] [Order article via Infotrieve]
  23. Little, H. J., Dolin, S. J., and Halsey, M. J. (1986) Life Sci. 39, 2059-2065[CrossRef][Medline] [Order article via Infotrieve]
  24. Littleton, J. M., Little, H. J., and Whittington, M. A. (1990) Psychopharmacology 100, 387-392[CrossRef][Medline] [Order article via Infotrieve]
  25. Brennan, C. H., Crabbe, J., and Littleton, J. M. (1990) Neuropharmacology 29, 429-432[CrossRef][Medline] [Order article via Infotrieve]
  26. Nishizuka, Y. (1992) Science 258, 607-614[Abstract/Free Full Text]
  27. Selbie, L. A., Schmitz-Peiffer, C., Sheng, Y., and Biden, T. J. (1993) J. Biol. Chem. 268, 24296-24302[Abstract/Free Full Text]
  28. Johannes, F.-J., Prestle, J., Eis, S., Oberhagemann, P., and Pfizenmaier, K. (1994) J. Biol. Chem. 269, 6140-6148[Abstract/Free Full Text]
  29. Messing, R. O., Sneade, A. B., and Savidge, B. (1990) J. Neurochem. 55, 1383-1389[Medline] [Order article via Infotrieve]
  30. Messing, R. O., Petersen, P. J., and Henrich, C. J. (1991) J. Biol. Chem. 266, 23428-23432[Abstract/Free Full Text]
  31. Roivainen, R., Hundle, B., and Messing, R. O. (1994) in Toward a Molecular Basis of Alcohol Use and Abuse (Jansson, B., Jörvall, H., Rydberg, U., Terenius, L., and Vallee, B. L., eds), pp. 29-38, Birkhäuser Verlag, Basel, Switzerland
  32. Johnson, J. A., Gray, M. O., Chen, C.-H., and Mochly-Rosen, D. (1996) J. Biol. Chem. 271, 24962-24966[Abstract/Free Full Text]
  33. Hundle, B., McMahon, T., Dadgar, J., Chen, C.-H., Mochly-Rosen, D., and Messing, R. O. (1997) J. Biol. Chem. 272, 15028-15035[Abstract/Free Full Text]
  34. Hundle, B., McMahon, T., Dadgar, J., and Messing, R. O. (1995) J. Biol. Chem. 270, 30134-30140[Abstract/Free Full Text]
  35. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275[Free Full Text]
  36. Greenberg, D. A., Carpenter, C. L., and Messing, R. O. (1986) J. Pharmacol. Exp. Ther. 238, 1021-1027[Abstract/Free Full Text]
  37. Gschwendt, M., Dieterich, S., Rennecke, J., Kittstein, W., Mueller, H.-J., and Johannes, F.-J. (1996) FEBS Lett. 392, 77-80[CrossRef][Medline] [Order article via Infotrieve]
  38. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D., and Kirilovsky, J. (1991) J. Biol. Chem. 266, 15771-15781[Abstract/Free Full Text]
  39. Clapham, D. E. (1995) Cell 80, 259-268[CrossRef][Medline] [Order article via Infotrieve]
  40. Ramkumar, V., and El-Fakahany, E. E. (1988) Eur. J. Pharmacol. 146, 73-83[CrossRef][Medline] [Order article via Infotrieve]
  41. Panza, G., Grebb, J. A., Sanna, E., Wright, A. G., Jr., and Hanbauer, I. (1985) Neuropharmacology 24, 1113-1117[CrossRef][Medline] [Order article via Infotrieve]
  42. Delorme, E. M., and McGee, R., Jr. (1986) Brain Res. 397, 189-192[CrossRef][Medline] [Order article via Infotrieve]
  43. Nikodijevic, B., Nikodijevic-Kedeva, D., Oshima, M., Paige, B., and Guroff, G. (1994) J. Neurosci. Res. 37, 71-82[CrossRef][Medline] [Order article via Infotrieve]
  44. McClesky, E. W. (1994) Curr. Opin. Neurobiol. 4, 304-312[CrossRef][Medline] [Order article via Infotrieve]
  45. Hui, A., Ellinor, P. T., Krizanova, O., Wang, J.-J., Diebold, R. J., and Schwartz, A. (1991) Neuron 7, 35-44[CrossRef][Medline] [Order article via Infotrieve]
  46. Snutch, T. P., Tomlinson, W. J., Leonard, J. P., and M., G. M. (1991) Neuron 7, 45-57[CrossRef][Medline] [Order article via Infotrieve]
  47. Williams, M. E., Feldman, D. H., McCue, A. F., Brenner, R., Velicelebi, G., Ellis, S. B., and Harpold, M. M. (1992) Neuron 8, 71-84[CrossRef][Medline] [Order article via Infotrieve]
  48. Hell, J. W., Westenbroek, R. E., Warner, C., Ahijanian, M. K., Prystay, W., Gilbert, M. M., Snutch, T. P., and Catterall, W. A. (1993) J. Cell Biol. 123, 949-962[Abstract/Free Full Text]
  49. Liu, H., Felix, R., Gurnett, C. A., De Waard, M., Witcher, D. R., and Campbell, K. P. (1996) J. Neurosci. 16, 7557-7565[Abstract/Free Full Text]
  50. Shistik, E., Ivanina, T., Puri, T., Hosey, M., and Dascal, N. (1995) J. Physiol. (Lond.) 489, 55-62[Abstract/Free Full Text]
  51. Hullin, R., Singer-Lahat, D., Freichel, M., Biel, M., Dascal, N., Hofmann, F., and Flockerzi, V. (1992) EMBO J. 11, 885-890[Medline] [Order article via Infotrieve]
  52. Massa, E., Kelly, K. M., Yule, D. I., Macdonald, R. L., and Uhler, M. D. (1995) Mol. Pharmacol. 47, 707-716[Abstract]
  53. Perez-Garcia, M. T., Kamp, T. J., and Marban, E. (1995) J. Gen. Physiol. 105, 289-306[Abstract/Free Full Text]
  54. Nishimura, S., Hiroshi, T., Hofmann, F., Flockerzi, V., and Imoto, K. (1993) FEBS Lett. 324, 283-286[CrossRef][Medline] [Order article via Infotrieve]
  55. Hirai, S., Izumi, Y., Higa, K., Kaibuchi, K., Mizuno, K., Osada, S., Suzuki, K., and Ohno, S. (1994) EMBO J. 13, 2331-2340[Medline] [Order article via Infotrieve]
  56. Li, W., Michieli, P., Alimandi, M., Lorenzi, M. V., Wu, Y., Wang, L.-H., Heidaran, M. A., and Pierce, J. H. (1996) Oncogene 13, 731-737[Medline] [Order article via Infotrieve]
  57. Mischak, H., Pierce, J. H., Goodnight, J., Kazanietz, M. G., Blumberg, P. M., and Mushinski, J. F. (1993) J. Biol. Chem. 268, 20110-20115[Abstract/Free Full Text]
  58. Fukumoto, S., Nishizawa, Y., Hosoi, M., Koyama, H., Yamakawa, K., Ohno, S., and Morii, H. (1997) J. Biol. Chem. 272, 13816-13822[Abstract/Free Full Text]
  59. Ghayur, T., Hugunin, M., Talanian, R. V., Ratnofsky, S., Quinlan, C., Emoto, Y., Pandey, P., Datta, R., Huang, Y. Y., Kharbanda, S., Allen, H., Kamen, R., Wong, W., and Kufe, D. (1996) J. Exp. Med. 184, 2399-2404[Abstract/Free Full Text]
  60. Ozawa, K., Szallasi, Z., Kazanietz, M. G., Blumberg, P. M., Mischak, H., Mushinski, J. F., and Beaven, M. A. (1993) J. Biol. Chem. 268, 1749-1756[Abstract/Free Full Text]
  61. Miettinen, S., Roivainen, R., Keinänen, R., Hökfelt, T., and Koistinaho, J. (1996) J. Neurosci. 16, 6236-6245[Abstract/Free Full Text]
  62. Dekker, L. V., and Peter, P. J. (1997) J. Biol. Chem. 272, 12747-12753[Abstract/Free Full Text]
  63. Aigner, L., and Caroni, P. (1993) J. Cell Biol. 123, 417-429[Abstract/Free Full Text]
  64. Ivins, K. J., Neve, K. A., Feller, D. J., Fidel, S. A., and Neve, R. L. (1993) J. Neurochem. 60, 626-633[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
E. N. Churchill, M.-H. Disatnik, G. R. Budas, and D. Mochly-Rosen
Ethanol for cardiac ischemia: the role of protein kinase c
Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 469 - 483.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
K. K. Maddali, D. H. Korzick, D. L. Tharp, and D. K. Bowles
PKC{delta} Mediates Testosterone-induced Increases in Coronary Smooth Muscle Cav1.2
J. Biol. Chem., December 30, 2005; 280(52): 43024 - 43029.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. E. Jung, M. B. Gatch, and J. W. Simpkins
Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms
Experimental Biology and Medicine, January 1, 2005; 230(1): 8 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. W. Hendricson, M. P. Thomas, M. J. Lippmann, and R. A. Morrisett
Suppression of L-Type Voltage-Gated Calcium Channel-Dependent Synaptic Plasticity by Ethanol: Analysis of Miniature Synaptic Currents and Dendritic Calcium Transients
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 550 - 558.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Tapia, L. J. Garcia-Marin, and R. T. Jensen
Cholecystokinin-stimulated Protein Kinase C-{delta} Kinase Activation, Tyrosine Phosphorylation, and Translocation Are Mediated by Src Tyrosine Kinases in Pancreatic Acinar Cells
J. Biol. Chem., September 12, 2003; 278(37): 35220 - 35230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. J. Nelson, K. Hellevuo, M. Yoshimura, and B. Tabakoff
Ethanol-induced Phosphorylation and Potentiation of the Activity of Type 7 Adenylyl Cyclase. INVOLVEMENT OF PROTEIN KINASE C delta
J. Biol. Chem., February 7, 2003; 278(7): 4552 - 4560.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Torocsik, J. M. Angelastro, and L. A. Greene
The Basic Region and Leucine Zipper Transcription Factor MafK Is a New Nerve Growth Factor-Responsive Immediate Early Gene That Regulates Neurite Outgrowth
J. Neurosci., October 15, 2002; 22(20): 8971 - 8980.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. K. Knott, A. M. Dopico, G. Dayanithi, J. Lemos, and S. N. Treistman
Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals
Mol. Pharmacol., July 1, 2002; 62(1): 135 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Katsura, Y. Mohri, K. Shuto, Y. Hai-Du, T. Amano, A. Tsujimura, M. Sasa, and S. Ohkuma
Up-regulation of L-type Voltage-dependent Calcium Channels after Long Term Exposure to Nicotine in Cerebral Cortical Neurons
J. Biol. Chem., March 1, 2002; 277(10): 7979 - 7988.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. Benes and S. P. Soltoff
Modulation of PKC{delta} tyrosine phosphorylation and activity in salivary and PC-12 cells by Src kinases
Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1498 - C1510.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. A. Dina, J. Barletta, X. Chen, A. Mutero, A. Martin, R. O. Messing, and J. D. Levine
Key Role for the Epsilon Isoform of Protein Kinase C in Painful Alcoholic Neuropathy in the Rat
J. Neurosci., November 15, 2000; 20(22): 8614 - 8619.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. RON, A. J. VAGTS, D. P. DOHRMAN, R. YAKA, Z. JIANG, L. YAO, J. CRABBE, J. E. GRISEL, and I. DIAMOND
Uncoupling of {beta}IIPKC from its targeting protein RACK1 in response to ethanol in cultured cells and mouse brain
FASEB J, November 1, 2000; 14(14): 2303 - 2314.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Guo, W. R. Giles, and C. A. Ward
Effect of hydrogen peroxide on the membrane currents of sinoatrial node cells from rabbit heart
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H992 - H999.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. McMahon, R. Andersen, P. Metten, J. C. Crabbe, and R. O. Messing
Protein Kinase C epsilon Mediates Up-Regulation of N-Type Calcium Channels by Ethanol
Mol. Pharmacol., January 1, 2000; 57(1): 53 - 58.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N.-K. Huang, Y.-W. Lin, C.-L. Huang, R. O. Messing, and Y. Chern
Activation of Protein Kinase A and Atypical Protein Kinase C by A2A Adenosine Receptors Antagonizes Apoptosis Due to Serum Deprivation in PC12 Cells
J. Biol. Chem., April 20, 2001; 276(17): 13838 - 13846.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Walter, T. McMahon, J. Dadgar, D. Wang, and R. O. Messing
Ethanol Regulates Calcium Channel Subunits by Protein Kinase C delta -dependent and -independent Mechanisms
J. Biol. Chem., August 11, 2000; 275(33): 25717 - 25722.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Zhao, W. Tian, and D. M. Cohen
Rottlerin inhibits tonicity-dependent expression and action of TonEBP in a PKCdelta -independent fashion
Am J Physiol Renal Physiol, April 1, 2002; 282(4): F710 - F717.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerstin Jr., E. H.
Right arrow Articles by Messing, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerstin Jr., E. H.
Right arrow Articles by Messing, R. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement